PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $668,000 | +38.9% | 1,073,000 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $481,000 | -57.3% | 1,073,000 | 0.0% | 0.01% | -58.3% |
| Q1 2016 | $1,127,000 | -64.4% | 1,073,000 | 0.0% | 0.01% | -58.6% |
| Q4 2015 | $3,165,000 | -6.7% | 1,073,000 | 0.0% | 0.03% | -14.7% |
| Q3 2015 | $3,391,000 | -46.6% | 1,073,000 | 0.0% | 0.03% | -27.7% |
| Q2 2015 | $6,352,000 | -44.6% | 1,073,000 | 0.0% | 0.05% | -52.0% |
| Q1 2015 | $11,470,000 | +13.8% | 1,073,000 | 0.0% | 0.10% | +2.1% |
| Q4 2014 | $10,075,000 | +22.3% | 1,073,000 | 0.0% | 0.10% | +11.6% |
| Q3 2014 | $8,241,000 | -18.8% | 1,073,000 | -5.1% | 0.09% | -27.7% |
| Q2 2014 | $10,153,000 | -13.7% | 1,130,600 | -48.6% | 0.12% | -17.9% |
| Q1 2014 | $11,762,000 | +101.1% | 2,198,500 | -5.3% | 0.14% | +68.6% |
| Q4 2013 | $5,848,000 | -7.4% | 2,320,800 | 0.0% | 0.09% | -23.9% |
| Q3 2013 | $6,313,000 | -24.6% | 2,320,800 | 0.0% | 0.11% | -36.5% |
| Q2 2013 | $8,378,000 | – | 2,320,800 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|